Annals of Diagnostic Paediatric Pathology

4. Ambros IM, Attarbaschi A, Rumpler, S,
Luegmayr A, Turkof E, Gadner H, Ambros
PF (2001): Neuroblastoma cells provoke
Schwann cell proliferation in vitro. Med
Pediatr Oncol 36:163-168
5. Ambros PF, Ambros IM (2001) Pathology
and biology guidelines for resectable and
unresectable neuroblastic tumors and bone
marrow examination guidelines. Med
Pediatr Oncol 37:492-504
6. Ambros PF, Ambros IM, Kerbl R, et al
(2001): Intratumoural heterogeneity of 1p
deletions and MYCN amplification in neuroblastomas.
Med Pediatr Oncol 36:1-4
7. Ambros PF, Ambros IM, Strehl S, et al
(1995) Regression and progression in
neuroblastoma. Does genetics predict
tumour behaviour Eur J Cancer
31A:510-515
8. Ambros P F, Mehes G, Ambros I M,
Ladenstein R (2003) Disseminated tumor
cells in the bone marrow - chances and
consequences of microscopical detection
methods. Cancer Lett 197:29-34
9. Bown, N, Cotterill S, Lastowska M, et
al (1999) Gain of chromosome arm 17q
and adverse outcome in patients with
neuroblastoma [see comments]. N Engl
J Med 340:1954-1961
10. Brodeur G M, Ambros PF (2000) Genetic
and biological markers of prognosis in
neuroblastoma. In: Brodeur GM, Sawada
T, Tsuchida Y, Voute PA (eds) Neuroblastoma,
Elsevier, Amsterdam, The Netherlands,
pp 355-365
11. Brodeur GM, Seeger RC, Schwab M,
Varmus HE, Bishop JM (1984) Amplification
of N-myc in untreated human neuroblastomas
correlates with advanced disease
stage. Science 224:1121-1124
12. D’Angio GJ, Evans AE, Koop CE
(1971) Special pattern of widespread
neuroblastoma with a favourable prognosis.
Lancet 1:1046-1049
13. Ejeskar K, Aburatani H, Abrahamsson
J, Kogner P, Martinsson T (1998) Loss
of heterozygosity of 3p markers in neuroblastoma
tumours implicate a tumoursuppressor
locus distal to the FHIT gene.
Br J Cancer 77:1787-1791
14. Evans AE, Chatten J, D’Angio GJ,
Gerson JM, Robinson J, Schnaufer L
(1980) A review of 17 IV-S neuroblastoma
patients at the Children’s Hospital
of Philadelphia. Cancer 45: 833-839
15. Guo C, White PS, Weiss MJ, Hogarty
MD, et al (1999) Allelic deletion at
11q23 is common in MYCN single copy
neuroblastomas. Oncogene 18:4948-
4957
16. Hiyama E, Hiyama K, Ohtsu K,
Yamaoka H, Ichikawa T, Shay JW,
Yokoyama T (1997) Telomerase activity
in neuroblastoma: is it a prognostic
indicator of clinical behaviour Eur J
Cancer 33:1932-1936
17. Horibe K, Fukuda M, Miyajima Y,
Matsumoto K, Kondo M, Inaba J,
Miyashita Y (2001) Outcome prediction
by molecular detection of minimal residual
disease in bone marrow for advanced
neuroblastoma. Med Pediatr
Oncol 36:203-204
18. Kogner P, et al (1994) Trk mRNA and
low affinity nerve growth factor receptor
mRNA expression and triploid DNA content
in favorable neuroblastoma tumors.
Prog Clin Biol Res 385:137-145
19. Ladenstein R, Ambros IM, Potschger U,
et al (2001) Prognostic significance of
DNA di-tetraploidy in neuroblastoma.
Med Pediatr Oncol 36:83-92
20. Lastowska M, Cotterill S, Bown N, et
al (2002) Breakpoint position on 17q
identifies the most aggressive neuroblastoma
tumors. Genes Chromosomes Cancer
34:428-36
21. Look AT, Hayes FA, Shuster JJ, et al.
(1991) Clinical relevance of tumor cell
ploidy and N-myc gene amplification in
childhood neuroblastoma: a Pediatric
Oncology Group study. J Clin Oncol
9:581-591
22. Luttikhuis ME, Powell JE, Rees SA, et
al (2001) Neuroblastomas with chromosome
11q loss and single copy MYCN
comprise a biologically distinct group
of tumours with adverse prognosis. Br J
Cancer 85:531-537
23. Marchionni MA, Goodearl AD, Chen
MS, et al (1993) Glial growth factors
are alternatively spliced erbB2 ligands
expressed in the nervous system [see
comments]. Nature 362:312-318
24. Maris JM, Weiss MJ, Mosse Y, et al
(2002) Evidence for a hereditary neuroblastoma
predisposition locus at chromosome
16p12-13. Cancer Res
62:6651-6658
25. Minghetti L, Goodearl AD, Mistry K,
Stroobant P (1996) Glial growth factors
I-III are specific mitogens for glial cells.
J Neurosci Res 43:684-693
26. Morrissey TK, Levi AD, Nuijens A,
Sliwkowski, MX, Bunge RP (1995)
Axon-induced mitogenesis of human
Schwann cells involves heregulin and
p185erbB2. Proc Natl Acad Sci USA
92:1431-1435
27. Nakagawara A, et al (1993) Association
between high levels of expression of the
TRK gene and favorable outcome in
human neuroblastoma. N Engl J Med
328:847-854
28. Panzer-Grumayer ER, Schneider M,
Panzer S, Fasching K, Gadner H (2000)
Rapid molecular response during early
induction chemotherapy predicts a good
outcome in childhood acute lymphoblastic
leukemia. Blood 95:790-794
29. Poremba C, Willenbring H, Hero B, et
al (1999) Telomerase activity distinguishes
between neuroblastomas with
good and poor prognosis [In Process Citation].
Ann Oncol 10:715-721
30. Reynolds ML, Woolf CJ (1993) Reciprocal
Schwann cell-axon interactions.
Curr Opin Neurobiol 3:683-693
31. Saarinen UM, Wikstrom S, Makipernaa
A, et al (1996 In vivo purging of bone
marrow in children with poor-risk neuroblastoma
for marrow collection and
autologous bone marrow transplantation.
J Clin Oncol 14:2791-2802
32. Seeger RC, Brodeur GM, Sather H,
Dalton A, Siegel SE, Wong KY,
Hammond D (1985) Association of
multiple copies of the N-myc oncogene
with rapid progression of neuroblastomas.
N Engl J Med 313:1111-1116
33. Seeger RC, Reynolds CP, Gallego R,
Stram DO, Gerbing RB, Matthay KK
(2000) Quantitative tumor cell content
of bone marrow and blood as a predictor
of outcome in stage IV neuroblastoma:
a Children’s Cancer Group Study.
J Clin Oncol 18:4067-4076
34. Snider WD (1994) Functions of the
neurotrophins during nervous system
development: what the knockouts are
teaching us. Cell 77:627-638
35. Spitz R, Hero B, Ernestus K, Berthold
F (2003) Deletions in chromosome arms
3p and 11q are new prognostic markers
in localized and 4s neuroblastoma. Clin
Cancer Res 9:52-58
36. Spitz R, Hero B, Ernestus K, Berthold
F (2003) Gain of distal chromosome arm
17q is not associated with poor prognosis
in neuroblastoma. Clin Cancer Res
9:4835-4840
37. Tsokos M, Scarpa S, Ross RA, Triche TJ
(1987) Differentiation of human neuroblastoma
recapitulates neural crest development.
Study of morphology, neurotransmitter
enzymes, and extracellular matrix proteins.
Am J Pathol 128:484-96
38. van Dongen JJ, Seriu T, Panzer-
Grumayer ER, et al (1998) Prognostic
value of minimal residual disease in
acute lymphoblastic leukaemia in childhood.
Lancet 352:1731-1738
39. van Roy N, Laureys G, Van, GM, et al
(1997) Analysis of 1;17 translocation
breakpoints in neuroblastoma: implications
for mapping of neuroblastoma
genes. Eur J Cancer 33:1974-1978
40. Vandesompele J, Van RN, Van GM, et
al (1998) Genetic heterogeneity of neuroblastoma
studied by comparative genomic
hybridization. Genes Chromosomes
Cancer 23:141-152
41. Yamamoto K, Hanada R, Kikuchi A, et al
(1998) Spontaneous regression of localized
neuroblastoma detected by mass
screening. J Clin Oncol 16:1265-1269